You are here

A HIGHLY SELECTIVE PROCESS FOR SEPARATING ENANTIOMERS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 14042
Amount: $49,926.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1990
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
64550 Research Rd
Bend, OR 97701
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Paul Van Eikeren
 (503) 382-4100
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THIS WORK IS DIRECTED TOWARD THE INVESTIGATION OF A NEW MEMBRANE-BASED PROCESS FOR THE SEPARATION OF ENANTIOMERS IN A RACEMIC MIXTURE. MANY BIOLOGICALLY ACTIVE SUBSTANCES ARE CHIRAL, AND IN GENERAL ONLY ONE OF THE ENANTIOMERS IN THE RACEMIC MIXTURE PRODUCES THE DESIRED BIOLOGICAL ACTIVITY. FREQUENTLY, THE UNWANTED ENANTIOMER INHIBITS THE DESIRED BIOLOGICAL ACTIVITY OF THE ACTIVE ENANTIOMER AND/OR EXHIBITSUNDESIRABLE SIDE EFFECTS. THE BEST CURRENTLY AVAILABLE ENANTIOMER RESOLUTION SCHEMES (E.G., FRACTIONAL CRYSTALLIZATION AND CHIRAL CHROMATOGRAPHY)HAVE A NUMBER OF DRAWBACKS, INCLUDING THE FOLLOWING: (1) THEY HAVE LOW RESOLUTION, PARTICULARLY WHEN SCALED UP TO A PRACTICAL SIZE; (2) THEY ARE LABOR INTENSIVE; AND (3) THEY ARE DIFFICULT TO OPERATE CONTINUOUSLY. THE NEW MEMBRANE-BASED PROCESS FOR ENANTIOMER RESOLUTION EMPLOYS A MOBILE CARRIER IN A LIQUID-MEMBRANE OPERATION. DURING PHASE I, THE FEASIBILITY OF THE PROCESS FOR THE ISOLATION OF D-PROPRANOLOL, AN IMPORTANT BETA-BLOCKER DRUG, FROM A RACEMIC MIXTURE OF D,L-PROPRANOLOL WILL BE DEMONSTRATED.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government